RGEN
REPLIGEN CORP
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$179.95
+0.94%Forward multiples
Based on analyst estimates
- P/E forward
- 73.96x
- P/E 2026E
- 84.58x
- P/E 2027E
- 65.82x
- P/E 2028E
- 50.97x
- P/S forward
- 11.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.50x
- Price / sales
- 14.28x
- Price / cash flow
- 88.58x
Enterprise value
- Enterprise value
- $11.3B
- EV / sales
- 14.07x
- EV / EBITDA
- 90.03x
- EV / EBIT
- 598.78x
- Market cap
- $11.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026